ciltacabtagene autoleucel
janssen
['mmsm', 'cartitude-2', 'multiple #myeloma', 'cilta-cel']
an update from #asco22 and #eha2022 of the cartitude-2 trial reports a 100% orr with cilta-cel in patients with multiple #myeloma relapsing early after 1 prior line of therapy. read the latest here #mmsm #cartcell 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma